Literature DB >> 11394877

Structure and expression of the human histamine H4-receptor gene.

F Cogé1, S P Guénin, H Rique, J A Boutin, J P Galizzi.   

Abstract

We report the characterization by genomics-based approach of the human H4-receptor gene structure. The H4-receptor gene have been mapped by radiation hybrid experiments (Gene Bridge 4) on chromosome 18q11.2, between the AFMBB11WH5 and CHLC.GATA85D10 markers. The H4-receptor gene spans more than 21 kbp and contains three exons separated by two large introns (>7 kbp). RT-PCR analysis showed that the H4-receptor gene encoded a 3.7 kb mRNA which did not seem to be alternatively spliced within its coding region. The H4-receptor transcripts were found to be highly expressed in peripheral tissues implicated in inflammatory responses such as leukocytes, spleen, lung, and liver. In addition, low expression level of the H4-receptor mRNA was also detected in several human brain regions. Analysis of the 5'-flanking region of the H4-receptor gene did not reveal the existence of canonical TATA or CAAT-box. However, several putative regulatory elements mediating TNFalpha or IL-6-stimulated transcriptional activation were detected. The uteroglobin promoter binding factor, known to mediate anti-inflammatory response of uteroglobin, in the lung, was also found in this region. Thus, the description of the H4-receptor gene promoter region will facilitate the elucidation of its transcriptional control by factors secreted during inflammatory responses. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11394877     DOI: 10.1006/bbrc.2001.4976

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

Review 1.  Histamine H₄ receptors in the gastrointestinal tract.

Authors:  A Deiteren; J G De Man; P A Pelckmans; B Y De Winter
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

2.  Commercially available antibodies against human and murine histamine H₄-receptor lack specificity.

Authors:  Silke Beermann; Roland Seifert; Detlef Neumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-11-10       Impact factor: 3.000

3.  Association between HRH4 polymorphisms and ankylosing spondylitis susceptibility.

Authors:  Bo Ran; Yongcheng Wang; Yonggang Zhang; Keya Mao; Yan Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

4.  Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.

Authors:  Florence Gbahou; Ludwig Vincent; Marie Humbert-Claude; Joel Tardivel-Lacombe; Claude Chabret; Jean-Michel Arrang
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

5.  Potentiation of NF-kappaB-dependent transcription and inflammatory mediator release by histamine in human airway epithelial cells.

Authors:  N S Holden; W Gong; E M King; M Kaur; M A Giembycz; R Newton
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

Review 6.  Molecular and biochemical pharmacology of the histamine H4 receptor.

Authors:  Rob Leurs; Paul L Chazot; Fiona C Shenton; Herman D Lim; Iwan J P de Esch
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

Review 7.  The role of histamine H4 receptor in immune and inflammatory disorders.

Authors:  E Zampeli; E Tiligada
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

8.  Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract.

Authors:  L E Sander; A Lorentz; G Sellge; M Coëffier; M Neipp; T Veres; T Frieling; P N Meier; M P Manns; S C Bischoff
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

9.  Expression and function of histamine H4 receptor in mouse splenic dendritic cells.

Authors:  T Simon; I Jelinek; Gy Apponyi; V László; E Rajnavölgyi; A Falus
Journal:  Inflamm Res       Date:  2010-03       Impact factor: 4.575

10.  Histamine H4-receptor expression in the brain?

Authors:  Erich H Schneider; Detlef Neumann; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-26       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.